ATE293614T1 - Nicht-steroidale polyzyklische sulfamat-derivate, deren herstellung und deren verwendung als östron sulfatase inhibitoren - Google Patents

Nicht-steroidale polyzyklische sulfamat-derivate, deren herstellung und deren verwendung als östron sulfatase inhibitoren

Info

Publication number
ATE293614T1
ATE293614T1 AT97903494T AT97903494T ATE293614T1 AT E293614 T1 ATE293614 T1 AT E293614T1 AT 97903494 T AT97903494 T AT 97903494T AT 97903494 T AT97903494 T AT 97903494T AT E293614 T1 ATE293614 T1 AT E293614T1
Authority
AT
Austria
Prior art keywords
oestron
sulfamat
derivatives
preparation
sulfatase inhibitors
Prior art date
Application number
AT97903494T
Other languages
English (en)
Inventor
Michael John Reed
Barry Victor Lloyd Potter
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Application granted granted Critical
Publication of ATE293614T1 publication Critical patent/ATE293614T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97903494T 1996-02-16 1997-02-17 Nicht-steroidale polyzyklische sulfamat-derivate, deren herstellung und deren verwendung als östron sulfatase inhibitoren ATE293614T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603325.3A GB9603325D0 (en) 1996-02-16 1996-02-16 A compound
PCT/GB1997/000444 WO1997030041A1 (en) 1996-02-16 1997-02-17 Non-steroidal polycyclic ring sulphamate derivatives, their preparation and their use as oestrone sulphatase inhibitors

Publications (1)

Publication Number Publication Date
ATE293614T1 true ATE293614T1 (de) 2005-05-15

Family

ID=10788910

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903494T ATE293614T1 (de) 1996-02-16 1997-02-17 Nicht-steroidale polyzyklische sulfamat-derivate, deren herstellung und deren verwendung als östron sulfatase inhibitoren

Country Status (14)

Country Link
US (1) US6239169B1 (de)
EP (2) EP1577308A3 (de)
JP (2) JP4047927B2 (de)
CN (3) CN1989961A (de)
AT (1) ATE293614T1 (de)
AU (1) AU1804197A (de)
CY (1) CY2559B1 (de)
DE (1) DE69733061T2 (de)
ES (1) ES2238078T3 (de)
GB (1) GB9603325D0 (de)
IL (1) IL125752A (de)
NZ (1) NZ331326A (de)
PT (1) PT880514E (de)
WO (1) WO1997030041A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
GB9604709D0 (en) * 1996-03-05 1996-05-01 Imperial College A compound
US6903084B2 (en) 1991-08-29 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US6506792B1 (en) 1997-03-04 2003-01-14 Sterix Limited Compounds that inhibit oestrone sulphatase and/or aromatase and methods for making and using
US6921776B1 (en) * 1996-02-16 2005-07-26 Sterix Limited Compound
ATE286038T1 (de) * 1996-03-05 2005-01-15 Sterix Ltd Verbindungen mit sulfonsäure-amidgruppe
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
GB2331988B (en) 1997-12-04 2003-04-16 Imperial College Polycyclic sulphamate inhibitors or oestrone sulphatase
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
JP2000309599A (ja) 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
IL145995A0 (en) 1999-04-30 2002-07-25 Sterix Ltd Use
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
WO2002015910A1 (en) 2000-08-18 2002-02-28 Sterix Limited 2-substituted estradiol derivative for inhibiting superoxid dismutase
US6632835B2 (en) * 2001-02-22 2003-10-14 Nanodesign Inc. Dibenzo[c]chromen-6-one derivatives as anti-cancer agents
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
GB0624105D0 (en) * 2006-12-01 2007-01-10 Sterix Ltd Use
JP5543920B2 (ja) 2007-09-17 2014-07-09 プレグレム エスアー 閉経前の女性におけるエストロゲン依存症状の治療
FR2942225B1 (fr) * 2009-02-13 2013-03-01 Ipsen Pharma Sas Variete i du 6-oxo-6,7,8,9,10,11-hexahydroclyclohepta5°c!chromen-3 yl sulfamate de granulometrie reduite
US8691281B2 (en) 2009-02-13 2014-04-08 Ipsen Pharma S.A.S. Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (C)chromen-3-yl sulfamate and polymorphs thereof
FR2942226B1 (fr) * 2009-02-13 2011-02-25 Ipsen Pharma Sas Nouveau polymorphe cristallin du 6-oxo+6,7,8,9,10,11-hexahydrocyclohepta°c!chromen-3-yl sulfamate
RU2011137516A (ru) * 2009-02-13 2013-03-20 Ипсен Фарма С.А.С. ТВЕРДАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ 6-ОКСО-6,7,8,9,10,11-ГЕКСАГИДРОЦИКЛОГЕПТА[c]ХРОМЕН-3-ИЛСУЛЬФАМАТ И ЕГО ПОЛИФОРМЫ
WO2011151061A1 (en) 2010-06-03 2011-12-08 Ipsen Pharma S.A.S. Al035301, a biomarker for breast cancer
CN104606186B (zh) * 2014-11-19 2017-09-12 北京工业大学 氟代7‑羟基香豆素化合物在蛋白激酶抑制剂或/和抗肿瘤药物中的应用
AU2019291061A1 (en) 2018-06-19 2021-02-04 Universidad Pablo De Olavide Compositions for treating and/or preventing protein-aggregation diseases
RU2752086C1 (ru) 2020-04-27 2021-07-22 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новое соединение [2-(диметиламино)-2-фенилбутил]-3,4,5-триметоксибензоата 4-метил-2н-хромен-2-он-7-илсульфат и его применение
CN112480055B (zh) * 2020-12-11 2022-10-21 肇庆学院 一种橙皮素衍生物及其合成方法与用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3243158A1 (de) * 1982-11-23 1984-05-24 Basf Ag, 6700 Ludwigshafen Neue sulfonsaeureester von hydroxycumarinen, ihre herstellung und sie enthaltende arzneimittel
FR2543140B1 (fr) 1983-03-24 1985-06-21 Cortial Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
PT94305B (pt) 1989-06-12 1997-02-28 Robins Co Inc A H Processo para a preparacao de compostos tendo um ou mais radicais aminossulfoniloxi uteis como produtos farmaceuticos
US5192785A (en) * 1989-09-03 1993-03-09 A. H. Robins Company, Incorporated Sulfamates as antiglaucoma agents
US5025031A (en) * 1989-11-30 1991-06-18 A. H. Robins Co., Inc. Aryl and aryloxyalkyl sulfamate esters useful as anticonvulsants
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
GB9118478D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
ATE286038T1 (de) 1996-03-05 2005-01-15 Sterix Ltd Verbindungen mit sulfonsäure-amidgruppe

Also Published As

Publication number Publication date
EP1577308A3 (de) 2007-08-29
GB9603325D0 (en) 1996-04-17
NZ331326A (en) 2000-03-27
ES2238078T3 (es) 2005-08-16
IL125752A0 (en) 1999-04-11
WO1997030041A1 (en) 1997-08-21
CY2559B1 (en) 2008-07-02
DE69733061D1 (de) 2005-05-25
EP1577308A2 (de) 2005-09-21
PT880514E (pt) 2005-08-31
EP0880514B1 (de) 2005-04-20
JP2008001723A (ja) 2008-01-10
DE69733061T2 (de) 2005-08-18
AU1804197A (en) 1997-09-02
EP0880514A1 (de) 1998-12-02
JP4949982B2 (ja) 2012-06-13
CN1989961A (zh) 2007-07-04
US6239169B1 (en) 2001-05-29
JP2000504717A (ja) 2000-04-18
CN1701790A (zh) 2005-11-30
CN1210272C (zh) 2005-07-13
CN100376244C (zh) 2008-03-26
CN1216044A (zh) 1999-05-05
JP4047927B2 (ja) 2008-02-13
IL125752A (en) 2007-07-04

Similar Documents

Publication Publication Date Title
ATE293614T1 (de) Nicht-steroidale polyzyklische sulfamat-derivate, deren herstellung und deren verwendung als östron sulfatase inhibitoren
FI962350A0 (fi) BPM-12, BMP-13 sekä niiden jännettä indusoivat koostumukset
ES2186783T3 (es) Derivados de la dolastatina, su preparacion y uso.
DE69739051D1 (de) Östrogen-Sulfamate als Sulfataseinhibitoren
BR9711586A (pt) Compostos e uso dos mesmo
ATE265997T1 (de) Substituierte tetrahydronaphthalin- und dihydronaphthalin-derivate mit einer retinoiden und/oder retinoid antagonist-ähnlichen biologischen aktivität
GB2331988B (en) Polycyclic sulphamate inhibitors or oestrone sulphatase
GB2331987B (en) Polycyclic sulphamate inhibitors of oestrone sulphatase
ATE320422T1 (de) Metalloproteinase inhibitoren
DE69623819D1 (de) Furan- und thiophencarbothioamid derivate, deren herstellung und deren verwendung als inhibitoren der replikation von hiv-1 und hiv-1 mutanten
TR200000637T2 (tr) Benzoksazin ve benzotiazin türevleri ve bunların ilaçlarda kullanımı.
DE69003578D1 (de) Gasentladungsroehre und stromversorgungseinrichtung.
DE68914522D1 (de) Isobenzothiazolon als chromogenische Thiol-Indikatoren und dessen Derivate.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
DE69735015D1 (de) Neue Creatin-amidinohydrolase, ihre Herstellung und Verwendung
ES2166026T3 (es) Derivados de 1,2,3-benzotiadiazol y su uso como microbicidas.
ATE275824T1 (de) Antiadhäsive sterole und sterolderivate
SE8502865D0 (sv) Naphtoxazine, ihre herstellung und verwendung
ES2175228T3 (es) Metilsulfomicina i, un procedimiento para su produccion y su uso.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0880514

Country of ref document: EP